Skip to main content

Table 1 Results of the linear regression analysis of daptomycin concentrations and PT-INR

From: Dose-dependent effect of daptomycin on the artificial prolongation of prothrombin time in coagulation abnormalities: in vitro verification

Reagent Plasma group R2 β SE (β) P-value
1: HemosIL RecombiPlasTin 2G A (INR 1) 0.74 2.2 × 10−4 3.3 × 10−5 < 0.0001
B (warfarin, INR 2) 0.97 1.5 × 10−3 6.0 × 10−5 < 0.0001
C (warfarin, INR 3) 0.94 2.5 × 10−3 1.5 × 10−4 < 0.0001
D (LC, INR 2) 0.96 1.3 × 10−3 6.5 × 10−5 < 0.0001
2: Neoplastin Plus A (INR 1) 0.76 5.1 × 10−4 7.3 × 10−5 < 0.0001
B (warfarin, INR 2) 0.75 8.6 × 10−4 1.2 × 10−4 < 0.0001
C (warfarin, INR 3) 0.94 1.9 × 10−3 1.3 × 10−4 < 0.0001
D (LC, INR 2) 0.89 1.4 × 10−3 1.2 × 10−4 < 0.0001
3: STA Neoplastin R A (INR 1) 0.88 6.6 × 10−4 6.0 × 10−5 < 0.0001
B (warfarin, INR 2) 0.95 2.4 × 10−3 1.3 × 10−4 < 0.0001
C (warfarin, INR 3) 0.97 3.3 × 10−3 1.6 × 10−4 < 0.0001
D (LC, INR 2) 0.99 2.2 × 10−3 4.7 × 10−5 < 0.0001
  1. INR international normalized ratio, SE standard error, LC liver cirrhosis